IP Library Granted Patent US 10,231,907
Granted Patent B2
US 10,231,907 · App. 14/751,527 · Granted Mar 19, 2019

Compositions for improving the health and appearance of skin

Inventors: Jeff Avila (Millbrae, CA); Geoffrey Brooks (Reno, NV); Anthony G. Day (San Francisco, CA); Aravind Somanchi (Redwood City, CA)
Assignee: Algenist Holdings, Inc.
A61K8/0241A61K8/73A61K8/9706A61Q19/08C08B37/0003C12P19/04C12R1/89
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,231,907
App. No.
14/751,527
Granted
Mar 19, 2019
Kind
B2
Abstract

Provided herein are microalgal skin care compositions and methods of improving the health and appearance of skin. Also provided are methods of using polysaccharides for applications such as topical personal care products, cosmetics, and wrinkle reduction compositions. The invention also provides novel decolorized microalgal compositions useful for improving the health and appearance of skin. The invention also includes insoluble polysaccharide particles for application to human skin.

Claims (33)

1. A gel, lotion, cream or ointment composition suitable for topical administration comprising microalgal exopolysaccharide particles, the exopolysaccharide produced by microalgae of the genus Parachlorella , wherein the exopolysaccharide particles are made by:

culturing microalgae cells in a culture medium so that exopolysaccharide is secreted by the microalgal cells into the culture medium;

separating the exopolysaccharide from the microalgal cells to create a purified exopolysaccharide;

heating, in two parts, the purified exopolysaccharide, the first part being performed at a temperature in the range of 60° C. to 100° C. and the second part being performed at a temperature range of 148° C.-160° C. so as to render it partially insoluble in water, and so that it forms a polysaccharide gel in water; and

generating particles having an average size of between 0.1 and 400 microns from the heated exopolysaccharide, wherein the particles increase in volume on contact with water by at least 100% compared to their anhydrous volume; and

the particles increase in volume for at least 4 hours, and

wherein the composition when applied to mammalian skin reduces the presence of crow's feet fine lines/wrinkles, increases skin elasticity, increases skin moisture, or decreases transepidermal water loss.

2. The composition of claim 1 , wherein the particles increase in volume on contact with water by at least 200% compared to their anhydrous volume.

3. The composition of claim 1 , wherein the composition further comprises between 50-97% ethylhexyl palmitate, 1-5% silica dimethyl silylate, 0.1-3% butylene glycol, and 0.1-3% of one or more preservative selected from the group consisting of diocide, dowicil 200, and methyl paraben.

4. The composition of claim 1 , wherein the particles are generated by milling the heated purified exopolysaccharide.

5. The composition of claim 1 , further comprising at least one ingredient selected from the group consisting of beta carotene, lutein, astaxanthin, vitamin C, vitamin E, vitamin A, and coenzyme Q10, a peptide, an acetylated peptide, oil soluble a-hydroxy acid, an alkyl lactate, and salicylic acid.

6. A gel, lotion, cream or ointment composition suitable for topical administration comprising microalgal exopolysaccharide particles, the exopolysaccharide produced by microalgae of the genus Parachlorella , wherein the exopolysaccharide particles are made by:

culturing microalgae cells in a culture medium so that exopolysaccharide is secreted by the microalgal cells into the culture medium;

separating the exopolysaccharide from the microalgal cells to create a purified exopolysaccharide;

heating, in two parts, the purified exopolysaccharide, the first part being performed at a temperature in the range of 60° C. to 100° C. and the second part being performed at a temperature of 148° C.-160° C. so as to render it partially insoluble in water, and so that it forms a polysaccharide gel in water; and

generating particles having an average size of between 0.1 and 400 microns from the heated exopolysaccharide, wherein the particles increase in volume on contact with water by at least 100% compared to their anhydrous volume; and

the particles increase in volume for at least 4 hours, and

wherein the composition when applied to mammalian skin cells stimulates an anti-inflammatory response in the mammalian cell, the anti-inflammatory response selected from the group consisting of reducing lymphocyte proliferation, reducing gamma interferon production, reducing interleukin la production, and reducing erythema.

7. The composition of claim 6 , wherein the particles increase in volume on contact with water by at least 200% compared to their anhydrous volume.

8. The composition of claim 6 , wherein the composition further comprises between 50-97% ethylhexyl palmitate, 1-5% silica dimethyl silylate, 0.1-3% butylene glycol, and 0.1-3% of one or more preservative selected from the group consisting of diocide, dowicil 200, and methyl paraben.

9. The composition of claim 6 , wherein the particles are generated by milling the heated purified exopolysaccharide.

10. The composition of claim 6 , further comprising at least one ingredient selected from the group consisting of beta carotene, lutein, astaxanthin, vitamin C, vitamin E, vitamin A, and coenzyme Q10, a peptide, an acetylated peptide, oil soluble a-hydroxy acid, an alkyl lactate, and salicylic acid.

11. A gel, lotion, cream or ointment composition suitable for topical administration comprising microalgal exopolysaccharide particles, the exopolysaccharide produced by microalgae of the genus Parachlorella , wherein the exopolysaccharide particles are made by:

culturing microalgae cells in a culture medium so that exopolysaccharide is secreted by the microalgal cells into the culture medium;

separating the exopolysaccharide from the microalgal cells to create a purified exopolysaccharide;

heating, in two parts, the purified exopolysaccharide, the first part being performed at a temperature in the range of 60° C. to 100° C. and the second part being performed at a temperature of 148° C.-160° C. so as to render it partially insoluble in water, and so that it forms a polysaccharide gel in water; and

generating particles having an average size of between 0.1 and 400 microns from the heated exopolysaccharide, wherein the particles increase in volume on contact with water by at least 100% compared to their anhydrous volume; and

the particles increase in volume for at least 4 hours, and

wherein the composition when applied to mammalian skin cells stimulates the synthesis of procollagen and/or elastin in the mammalian cell.

12. The composition of claim 11 , wherein the particles increase in volume on contact with water by at least 200% compared to their anhydrous volume.

13. The composition of claim 11 , wherein the composition further comprises between 50-97% ethylhexyl palmitate, 1-5% silica dimethyl silylate, 0.1-3% butylene glycol, and 0.1-3% of one or more preservative selected from the group consisting of diocide, dowicil 200, and methyl paraben.

14. The composition of claim 11 , wherein the particles are generated by milling the heated purified exopolysaccharide.

15. The composition of claim 11 , further comprising at least one ingredient selected from the group consisting of beta carotene, lutein, astaxanthin, vitamin C, vitamin E, vitamin A, and coenzyme Q10, a peptide, an acetylated peptide, oil soluble a-hydroxy acid, an alkyl lactate, and salicylic acid.

Assignments (6)
RELEASE OF SECURITY INTEREST Recorded Mar 1, 2023
From: SIENA LENDING GROUP LLC
To: ALGENIST BRANDS LLC
Reel/Frame 062845/0140 →
SECURITY INTEREST Recorded Mar 11, 2019
From: ALGENIST BRANDS, LLC
To: SIENA LENDING GROUP LLC
Reel/Frame 048560/0750 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 25, 2018
From: ALGENIST HOLDINGS, INC. C/O TENGRAM CAPITAL PARTNERS
To: ALGENIST BRANDS, LLC
Reel/Frame 046965/0076 →
SECURITY INTEREST Recorded Jul 20, 2017
From: ALGENIST BRANDS LLC
To: SIENA LENDING GROUP, LLC
Reel/Frame 043055/0421 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 15, 2016
From: TERRAVIA HOLDINGS, INC.
To: ALGENIST HOLDINGS, INC.
Reel/Frame 040992/0470 →
CHANGE OF NAME Recorded May 23, 2016
From: SOLAZYME, INC.
To: TERRAVIA HOLDINGS, INC.
Reel/Frame 038794/0867 →
Continuity (17)
Continuation 13531419 · Jun 22, 2012
Continuation 12176320 · Jul 18, 2008
Continuation In Part 11932782 · Oct 31, 2007
Continuation PCTUS2007001653 · Jan 19, 2007
Continuation In Part 11336426 · Jan 19, 2006
Continuation In Part 11336428 · Jan 19, 2006
Continuation In Part 11336430 · Jan 19, 2006
Continuation In Part 11336431 · Jan 19, 2006
Continuation In Part 11336656 · Jan 19, 2006
Continuation In Part 11337103 · Jan 19, 2006
Continuation In Part 11337171 · Jan 19, 2006
Provisional Application 60961173 · Jul 18, 2007
Provisional Application 60816967 · Jun 28, 2006
Provisional Application 60832091 · Jul 20, 2006
Provisional Application 60838452 · Aug 17, 2006
Provisional Application 60872072 · Nov 30, 2006
Related Publication 20150366791A1 · Dec 24, 2015